Pregnant women with heart disease: Placental characteristics and their association with fetal adverse events

References

• Opotowsky AR, Siddiqi OK, D’Souza B, Webb GD, Fernandes SM, Landzberg MJ. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012;98:145–51.
   PubMed Web of Science ®Google Scholar
• Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, Sermer M. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation. 2002;105:2179–84.
   PubMed Web of Science ®Google Scholar
• Koutrolou-Sotiropoulou P, Parikh PB, Miller C, Lima FV, Butler J, Stergiopoulos K. Impact of heart disease on maternal and fetal outcomes in pregnant women. Am J Cardiol. 2015;116:474–80.
   PubMed Web of Science ®Google Scholar
• Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, Mulder BJ, Oudijk MA, Roos-Hesselink JW, Cornette J, et al. investigators ZI. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation. 2013;128:2478–87.
   PubMed Web of Science ®Google Scholar
• Ueland K, Novy MJ, Metcalfe J. Hemodynamic responses of patients with heart disease to pregnancy and exercise. Am J Obstet Gynecol. 1972;113:47–59.
   PubMed Web of Science ®Google Scholar
• Wald RM, Silversides CK, Kingdom J, Toi A, Lau CS, Mason J, Colman JM, Sermer M, Siu SC. Maternal cardiac output and fetal Doppler predict adverse neonatal outcomes in pregnant women with heart disease. J Am Heart Assoc. 2015;4.
   Web of Science ®Google Scholar
• Aardema MW, Lander M, Oosterhof H, De Wolf BT, Aarnoudse JG. Doppler ultrasound screening predicts recurrence of poor pregnancy outcome in subsequent pregnancies, but not the recurrence of PIH or preeclampsia. Hypertens Pregnancy. 2000;19:281–88.
   PubMed Web of Science ®Google Scholar
• Langston C, Kaplan C, Macpherson T, Manci E, Peevy K, Clark B, Murtagh C, Cox S, Glenn G. Practice guideline for examination of the placenta: Developed by the placental pathology practice guideline development task force of the College of American Pathologists. Arch Pathol Lab Med. 1997;121:449–76.
   PubMed Web of Science ®Google Scholar
• Rayburn W. Mitral valve prolapse and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac problems in pregnancy: Diagnosis and management of maternal and fetal disease. 2nd ed. New York, NY: Alan R Liss, Inc; 1990. pp. 181–88.
   Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Chamber quantification Writing G, American Society of Echocardiography’s G, Standards C and European Association of E. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.
   PubMed Web of Science ®Google Scholar
• Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, et al. American Society of E. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1–23. quiz 101-2.
   PubMed Web of Science ®Google Scholar
• Ihlen H, Amlie JP, Dale J, Forfang K, Nitter-Hauge S, Otterstad JE, Simonsen S, Myhre E. Determination of cardiac output by Doppler echocardiography. Br Heart J. 1984;51:54–60.
   PubMedGoogle Scholar
• Redline RW. Placental pathology: Is it time to get serious? [Internet]. Contemporary OB/GYN. 2014 [cited 11 March 2016]. Available from: http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/content/tags/maternal-fetal-medicine/placental-pathology-it-time-get-serious?page=full.
   Google Scholar
• Van Oppen AC, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: A critical review. Obstet Gynecol. 1996;87:310–18.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9:147–60.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38:139–45.
   PubMed Web of Science ®Google Scholar
• Arias F, Rodriquez L, Sc R, Ft K. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168:585–91.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim YM. Acute atherosis of the uterine spiral arteries: Clinicopathologic implications. J Pathol Transl Med. 2015;49:462–71.
   PubMed Web of Science ®Google Scholar
• Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney DZ, Hladunewich MA. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: Insights into future vascular risk. Circulation. 2010;122:1846–53.
   PubMed Web of Science ®Google Scholar
• Gaillard R, Steegers EA, Tiemeier H, Hofman A, Jaddoe VW. Placental vascular dysfunction, fetal and childhood growth, and cardiovascular development: The generation R study. Circulation. 2013;128:2202–10.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–94.
   PubMed Web of Science ®Google Scholar
• Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH. Maternal cardiac function in fetal growth restriction. Bjog. 2006;113:784–91.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94:3246–50.
   PubMed Web of Science ®Google Scholar
• Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol. 2003;110(Suppl 1);S99–107.
   PubMedGoogle Scholar
• Godfrey KM. The role of the placenta in fetal programming: A review. Placenta. 2002;23(Suppl A);S20–7.
   PubMedGoogle Scholar
• Ganer Herman H, Miremberg H, Schreiber L, Bar J, Kovo M. The association between disproportionate birth weight to placental weight ratio, clinical outcome, and placental histopathological lesions. Fetal Diagn Ther. 2017;41:300–06.
   PubMed Web of Science ®Google Scholar
• Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, Derricott H, Evans MJ, Faye-Petersen OM, Gillan JE, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140:698–713.
   PubMed Web of Science ®Google Scholar